Pregled bibliografske jedinice broj: 504617
Malignant neuroleptic syndrome in psychopharmacotherapy of psychotic patients
Malignant neuroleptic syndrome in psychopharmacotherapy of psychotic patients // "Campaign on Schizophrenia 1995" - Workshop on: Critical Issues in the Treatment of Schizophrenia / Judd, LL ; Langer, SZ ; Mendlewicz, J ; Racagni, G ; Shibuya, T (ur.).
Firenza : München: International Academy for Biomedical and Drug Research, 1995. str. 156-156 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 504617 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Malignant neuroleptic syndrome in psychopharmacotherapy of psychotic patients
Autori
Folnegović-Šmalc, Vera ; Folnegović, Zdenko ; Makarić, Gordan ; Mimica, Ninoslav
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
"Campaign on Schizophrenia 1995" - Workshop on: Critical Issues in the Treatment of Schizophrenia
/ Judd, LL ; Langer, SZ ; Mendlewicz, J ; Racagni, G ; Shibuya, T - Firenza : München : International Academy for Biomedical and Drug Research, 1995, 156-156
Skup
Campaign on Schizophrenia, Workshop on: Critical Issues in the Treatment of Schizophrenia
Mjesto i datum
Firenca, Italija, 10.05.1995. - 12.05.1995
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Malignant neuroleptic syndrome; psychopharmacotherapy; psychosis
Sažetak
In a ten-year follow-up study of 3602 psychotic patients hospitalized at the Clinical Department of Psychiatric Hospital Vrapce In Zagreb, the efficacy and tolerance of psychotropic drugs were evaluated. The average number of hospitalizations was 2.6 per patient. The authors present the structure of drugs administered in certain phases of treatment, with regard to all drugs administered simultaneously, and the nature of side effects that appeared in any phase of the treatment. A special attention was paid to diagnostic of malignant neuroleptic syndrome (MNS). It was found in 18 patients, all of whom belonged to the age group between 35 and 61 years. Before the onset of MNS in those patients, psychopharmacotherapy was applied over one week to more than a year. A tendency towards the relapse of MNS was found in some patients. In 20.2% of the subjects, clozapine was administered as monotherapy. None of them developed MNS, so the authors conclude that clozapine is a psychotropic drug of choice in the patients suspect of developing MNS.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za psihijatriju Vrapče